This combination is tailored for patients whose tu
Post# of 147891
(Total Views: 486)
Posted On: 11/06/2024 10:12:08 PM
Quote:
Quote:
This combination is tailored for patients whose tumors express CCR5
Does this tailoring insure that those genetically inappropriate to the goals are excluded so as not to dilute efficacy?
If they are testing for CCR5 expression and it certainly looks like it, then it would exclude CCR5 delta 32 deletion double allele patients but not single allele.
(9)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼